Sayona Mining (ASX:SYA) announced the final results of its 2024 drilling campaign at the North American Lithium operation in Québec, confirming the project's large-scale, high-grade lithium potential.

Cosmo Metals (ASX:CMO) has completed the acquisition of the highly prospective Bingara and Nundle gold, antimony, and copper projects in northern New South Wales. Covering a combined area of 743km2 ...

El Salvador’s adoption of Bitcoin (CRYPTO:BTC) as legal tender in 2021 was presented as a move to boost economic growth, attract foreign investment, and provide financial inclusion for the unbanked ...

SRJ Technologies Group (ASX:SRJ) said that its subsidiary, Air Control Entech, has secured a £695,000 ($1.5 million) contract with a global Oil & Gas Supermajor for advanced inspection and emissions ...

RareX (ASX:REE) announced a partnership with Iluka Resources (ASX:ILU) to jointly pursue the development of the Mrima Hill rare earths-niobium-phosphate-manganese Project in Kwale County, Kenya. The ...

More than 70 cryptocurrency exchange-traded funds (ETFs) are currently under review by the US Securities and Exchange Commission (SEC) in 2025, with proposed products spanning a wide range of digital ...

A class-action lawsuit filed in the US District Court for the Southern District of New York accuses decentralised exchange Meteora, venture capital firm Kelsier Labs, and several executives of fraud ...

Kiwi insurer Tower (ASX:TWR) upgraded its full-year FY25 guidance for underlying net profit after tax, now expecting between NZ$70 million ($65.6 million) and NZ$80 million ($74.8 million), up from ...

Chinese fast-fashion giant Shein has topped $1 billion in annual Australian sales for the first time, underlining its rapid ascent as one of the country's largest online retailers. Newly lodged ...

Chilwa Minerals (ASX:CHW) reported its best mineralised zones to date from the latest sonic drilling campaign at the Mposa North deposit, part of the Chilwa Critical Minerals Project in southern ...

Recce Pharmaceuticals (ASX:RCE), a developer of synthetic anti-infectives, has received approval from the Human Research Ethics Committee to expand its ongoing Phase 2 clinical trial of RECCE 327 ...

Neurizon Therapeutics (ASX:NUZ), a clinical-stage biotech company developing treatments for neurodegenerative diseases, appointed Dan O'Connell as its new CFO. O’Connell brings over two decades of ...